Sponsor:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Reminder: NIH Natural Disaster Policy - Hurricane Michael
National Institutes of Health - Publication of the Revised NIH Grants Policy Statement (Rev. October 2018) for FY 2019
National Institutes of Health - Notice of Information: Re-Opening the Comment Period for an NIH Proposal to Amend the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules to Streamline Oversight of Human Gene Transfer Protocols
National Institutes of Health - Notice of Intent to Publish Parent Funding Opportunity Announcements for Basic Experimental Studies with Humans
National Institutes of Health - Notice of Participation of the National Institute on Aging (NIA) in PAR-18-714, "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)"
National Institute on Aging - PRE-SOLICITATION NOTICE: SIMIAN VACCINE EVALUATION UNITS (SVEUs)
National Institute of Allergy and Infectious Diseases - Notice of NCCIH Participation in PAR-18-714, "Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)"
National Center for Complementary and Integrative Health - Presolicitation Notice: Request for Proposals (RFP) N01CN87006-18 "PREVENT Cancer Preclinical Drug Development Program: cGMP Production of Vaccines and Biologicals for Cancer Prevention"
National Cancer Institute - Notice of Intent to Publish a Funding Opportunity Announcement for Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)
National Cancer Institute - Notice for a Pre-application Webinar for Biospecimen Funding Opportunity Announcement PAR-18-947 (U01)
National Cancer Institute - Notice of NIDA's participation in PAR-18-836 "Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)"
National Institute on Drug Abuse - Notice of NIDA's participation in PAR-18-835 "Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trial Optional)"
National Institute on Drug Abuse - Notice of NIDCD Participation in PAR-18-714-Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)
National Institute on Deafness and Other Communication Disorders - Notice of Clarification of Award Budget for PAR-18-656 NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
National Institute of Dental and Craniofacial Research - NIDDK Targeted SBIR Funding Opportunity Announcements Modified to Allow SBIR Direct-to-Phase II Applications
National Institute of Diabetes and Digestive and Kidney Diseases - Notice of Intent to Publish a Funding Opportunity Announcement for Development of Translational Devices to Treat Pain (U18 Clinical Trial Not Allowed)
National Institute of Biomedical Imaging and Bioengineering
National Center for Complementary and Integrative Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Neurological Disorders and Stroke - Notice Announcing NIEHS Use of RFA-ES-16-005 "Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21)" for Hurricanes Florence and Michael Response Research
National Institute of Environmental Health Sciences - Notice Announcing NIEHS Use PA-18-591 "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)" for Hurricane Florence Research Response
National Institute of Environmental Health Sciences - Notice Announcing NIEHS Use of PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)" for Hurricanes Florence and Michael Research Response
National Institute of Environmental Health Sciences - Changes in NIGMS Support of Integrated Predoctoral Dual-degree M.D.-Ph.D. Training through the Medical Scientist Training Program
National Institute of General Medical Sciences - Notice of NIGMS Participation in PA-19-029 Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)
National Institute of General Medical Sciences - Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NIGMS SBIR FOAs
National Institute of General Medical Sciences - Notice to Clarify the Participation of Foreign Scientists in PAR-17-340 "Collaborative Program Grant for Multidisciplinary Teams (RM1)"
National Institute of General Medical Sciences - NICHD Policy on Monitoring and Oversight of Clinical Trials
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Pre-Application Technical Assistance Webinar for RFA-HD-19-022, Reproductive Medicine Collaborative Clinical Trials Program (Collaborative R01 Clinical Trial Required)
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice Inviting the Community to Contribute to the Generation of NHGRI's '2020 Vision for Genomics'
National Human Genome Research Institute - Reinstatement of NIH SBIR Direct-to-Phase II Authority and Associated Updates to NHGRI Associated SBIR FOAs
National Human Genome Research Institute - Notice of Intent to Publish a Funding Opportunity Announcement for Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed)
National Human Genome Research Institute - Notice of Intent to Publish a Funding Opportunity Announcement for High Quality Human Reference Genomes (HQRG) (UM1 Clinical Trial Not Allowed)
National Human Genome Research Institute - Notice of Intent to Publish a Funding Opportunity Announcement for Research and Development for Genome Reference Representations (GRR) (U01, Clinical Trial Not Allowed)
National Human Genome Research Institute - Notice of NHLBI Participation in PA-19-029 "Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed) issued by the National Institutes of Health.
National Heart, Lung, and Blood Institute - Request for Information (RFI): Soliciting input for future research at the NHLBI regarding Late complications after allogeneic hematopoietic stem cell transplantation or autologous gene modified stem cell transplant for non-malignant blood disorders
National Heart, Lung, and Blood Institute - Request for Information (RFI): Understanding the Health of Women and the Role of Sex/Gender in Mechanisms of Heart, Lung, Blood, and Sleep Diseases and Disorders
National Heart, Lung, and Blood Institute - Notice of Change to Funding Opportunity Announcement, RFA-MD-18-012 Research Centers in Minority Institutions (RCMI) (U54 Clinical Trials Optional)" Regarding Late Applications
National Institute on Minority Health and Health Disparities - Notice of Information: NIMHs Interest in Areas of Stress Biology Research
National Institute of Mental Health - Notice to Extend PAR-18-941 Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Optional)
National Institute of Mental Health - Notice to Extend PAR-18-942 Neuromodulation/Neurostimulation Device Development for Mental Health Applications (R01 Clinical Trial Optional)
National Institute of Mental Health - Request for Information (RFI): Guidance on Current Clinical Experience with the Use of Ketamine for Suicide Prevention
National Institute of Mental Health - Notice of Intent to Publish a Funding Opportunity Announcement for Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Intent to Publish a Funding Opportunity Announcement for Translational Devices to Treat Pain (U44 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of Change to Application Due Date for Administrative Supplement for the NINDS Research Education Program for Residents and Fellow in Neurosurgery, Neuropathology, Neuroradiology and Emergency Medicine (Admin Supplement)
National Institute of Neurological Disorders and Stroke - Notice of Correction to Revise Application Due Dates for PAR-18-910 Limited Competition for NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (U01 Clinical Trial Required)
National Center for Advancing Translational Sciences - Notice of Correction to Revise Application Due Dates for NOT-TR-19-001 Notice of Availability of Administrative Supplements for Microphysiological Systems Developers: Development of Tissue Chips to Model Nociception, Opioid Addiction and Overdose
National Center for Advancing Translational Sciences - Notice of NIH Participation in the Ecology and Evolution of Infectious Diseases Program
John E. Fogarty International Center
National Institute of Allergy and Infectious Diseases
National Institute of General Medical Sciences - Notice of Change in Application Due Date for PAR-17-001 "Emerging Global Leader Award (K43)"
John E. Fogarty International Center
Requests for Applications
- Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R43/R44 Clinical Trial Not Allowed)
- Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R41/R42 Clinical Trial Not Allowed)
National Institute on Aging
- A Census of Cells and Circuits in the Aging Brain (R01 Clinical Trial Not Allowed)
National Institute on Aging
- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
Food and Drug Administration
- Reproductive Medicine Collaborative Clinical Trials Program (Collaborative R01 Clinical Trial Required)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Early Screening for Autism Spectrum Disorder (R01 Clinical Trial Not Allowed)
National Institute of Mental Health
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
- Early Screening for Autism Spectrum Disorder (R21 Clinical Trial Not Allowed)
National Institute of Mental Health
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Neurological Disorders and Stroke
- NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Research (P50 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
- NINDS Morris K. Udall Center without Walls for Parkinsons Disease Research (P20 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
- BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
National Eye Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
Program Announcements
- Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed)
- Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
National Center for Advancing Translational Sciences
National Cancer Institute
National Institute of Mental Health
National Library of Medicine
- Administrative Supplements to Cancer Center Support Grants to Strengthen NCI-Supported Community Outreach Capacity through Community Health Educators of the National Outreach Network (Admin Suppl Clinical Trial Not Allowed)
National Cancer Institute
- NLM Grants for Scholarly Works in Biomedicine and Health (G13 Clinical Trial Not Allowed)
National Library of Medicine
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
John E. Fogarty International Center
National Cancer Institute
National Human Genome Research Institute
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Research on Women's Health
- Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)
- Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke
National Eye Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Environmental Health Sciences
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Paul Below at paul-below@uiowa.edu, or Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu